Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 15.28
+0.36 (2.41%)
Oct 23, 2026, 3:04 PM CST
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 11.83 billion as of October 23, 2026. It is the 7,117th most valuable company in the world and the 1,354th biggest in China. Its market cap has decreased by 30.20% in one year.
Market Cap
11.83B
Enterprise Value
10.69B
Revenue
1.91B
Global Rank
Country Rank
#1,354 China
PE Ratio
22.70
ChartMarket Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 11.83B, an increase of 84.69%. That is a compound annual growth rate of 6.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 11.83B | -22.32% |
| Dec 31, 2025 | 15.23B | -32.96% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Double Medical Technology | 15.90B |
| MeHow Innovative | 13.54B |
| Shandong Weigao Blood Purification Products | 12.32B |
| Insight Lifetech | 11.88B |
| Cofoe Medical Technology | 11.49B |
| Qingdao Haier Biomedical Co.,Ltd | 10.57B |
| Shanghai MicroPort Endovascular MedTech | 10.40B |
| Beijing Balance Medical Technology | 9.93B |